Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Intravenous AOD-9604 Early human studies used single intravenous amounts of 25-400 mcg/kg
This lifts the subcutaneous layer away from muscle, ensuring the peptide deposits in the correct tissue layer
The peptide works specifically on adipose tissue through beta-3 adrenergic receptor modulation, triggering lipolysis while inhibiting lipogenesis, without affecting growth hormone levels, insulin sensitivity, or other metabolic systems
If there is clinical improvement and if a reticulocyte response is observed, the same amount may be given on alternate days for seven doses, then every 3 to 4 days for another 2 to 3 weeks
US$ 28.48
US$ 27.05
US$ 29.60
US$ 27.59
US$ 27.48
US$ 23.76
